top of page
Back
Niagen Biosciences Inc.
NASDAQ:NAGE
Stock
Asset detail
Buy Date
Buy Price
Current Price (*)
Var (%)
Status
-
-
-
-59.56
Active
(*) Price reflects last market close
Niagen Bioscience (NAGE) develops science-based nutritional products supporting cellular health and healthy aging through proprietary nicotinamide riboside (NR) technology.
Sector:
Healthcare
FINANCIAL SNAPSHOT
Market Cap
Revenue
Debt
Forward P/E
P/S Ratio
~500M USD
129M USD
2.82M USD
15.77x
4.20x
Note: Financial snapshot reflects company metrics at the time of position initiation.
Asset Performance
Weight:
🔒 MEMBER EXCLUSIVE
-
Asset Risk (0-7)
🔒 MEMBER EXCLUSIVE
POSITION MANAGEMENT
Stop Loss Management
Initial
Current
Take Profit Management
Price
Distance
Distance
Price
Distance
Distance
-
-
-
Initial
-
-
-
-
-
-
Current
-
-
-
🔒 MEMBER EXCLUSIVE
Detailed position management, decision logs and ongoing updates are available to members.
Follow every decision, not just the final result.
INVESTMENT ANALYSIS
Niagen Bioscience is a biotechnology company specializing in nicotinamide riboside (NR), a patented ingredient that supports cellular health and healthy aging. The company develops science-based nutritional products backed by clinical research and intellectual property. NAGE operates in the growing longevity market, where increasing consumer awareness and product adoption may support long-term growth.
Niagen Bioscience is a biotechnology company specializing in nicotinamide riboside (NR), a patented ingredient that supports cellular health and healthy aging. The company develops science-based nutritional products backed by clinical research and intellectual property. NAGE operates in the growing longevity market, where increasing consumer awareness and product adoption may support long-term growth.
🔒 MEMBER EXCLUSIVE
Full investment analysis, including the investment thesis, key risks and thesis invalidation, is available to members.
DECISION LOGS
-
-
Price
-
-
-
-
-
bottom of page